| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -8,1 k € | -100.8% | 1,0 M € | +4408.1% | -24,2 k € | +63.4% | -66,2 k € | -2.7% | -64,4 k € | +0.4% | -64,7 k € | -124.0% | 269,6 k € | +313.7% | -126,2 k € | +10.7% | -141,2 k € | -16.3% | -121,4 k € | -24.3% | -97,7 k € | -11.0% | -88,0 k € | +47.5% | -167,6 k € | +35.8% | -261,1 k € | -0.0% | -261,1 k € | +1.1% | -264,0 k € | |
| EBITDA | -8,1 k € | +6.8% | -8,7 k € | +64.1% | -24,2 k € | +63.4% | -66,2 k € | -2.7% | -64,4 k € | +0.4% | -64,7 k € | -124.0% | 269,6 k € | +313.7% | -126,2 k € | +10.7% | -141,2 k € | -16.2% | -121,5 k € | -23.1% | -98,7 k € | -10.9% | -89,0 k € | +46.9% | -167,6 k € | +35.8% | -261,2 k € | +0.1% | -261,4 k € | +1.2% | -264,7 k € | |
| Operating profit | -8,1 k € | +6.8% | -8,7 k € | +64.1% | -24,2 k € | +63.4% | -66,2 k € | -2.7% | -64,4 k € | +0.4% | -64,7 k € | -124.0% | 269,6 k € | +313.7% | -126,2 k € | +10.7% | -141,2 k € | -16.2% | -121,5 k € | -23.1% | -98,7 k € | -10.9% | -89,0 k € | +46.9% | -167,6 k € | +35.8% | -261,2 k € | +0.1% | -261,4 k € | +1.2% | -264,7 k € | |
| Profit/loss | -8,5 k € | +6.8% | -9,1 k € | +65.0% | -25,9 k € | -101.0% | 2,5 M € | +171.5% | -3,5 M € | -781.5% | -398,9 k € | -357.5% | -87,2 k € | +81.3% | -466,4 k € | -264.3% | -128,0 k € | +82.8% | -743,5 k € | -688.6% | -94,3 k € | -171.5% | -34,7 k € | +76.5% | -147,6 k € | +40.6% | -248,7 k € | -0.3% | -247,8 k € | -36.0% | -182,2 k € | |
| Equity | 3,6 M € | -0.2% | 3,6 M € | -5.2% | 3,8 M € | -0.7% | 3,8 M € | +190.2% | 1,3 M € | -72.7% | 4,8 M € | -7.6% | 5,2 M € | -7.3% | 5,7 M € | -20.4% | 7,1 M € | -1.8% | 7,2 M € | +10.4% | 6,5 M € | +27.4% | 5,1 M € | -0.7% | 5,2 M € | -2.8% | 5,3 M € | -4.5% | 5,6 M € | +140.3% | 2,3 M € | |
| Total assets | 3,6 M € | -0.0% | 3,6 M € | -5.1% | 3,8 M € | -1.2% | 3,9 M € | +188.5% | 1,3 M € | -72.6% | 4,9 M € | -12.6% | 5,6 M € | -27.1% | 7,6 M € | +7.5% | 7,1 M € | -1.8% | 7,2 M € | +10.5% | 6,5 M € | +27.2% | 5,1 M € | -0.7% | 5,2 M € | -2.8% | 5,3 M € | -4.5% | 5,6 M € | +140.0% | 2,3 M € | |
| Cash | 2,4 k € | -34.5% | 3,7 k € | -63.6% | 10,3 k € | -75.6% | 42,1 k € | -85.7% | 294,9 k € | -57.7% | 697,4 k € | -2.5% | 715,6 k € | -79.9% | 3,6 M € | +230.2% | 1,1 M € | -24.5% | 1,4 M € | -7.8% | 1,6 M € | +132.9% | 666,1 k € | -63.7% | 1,8 M € | -20.4% | 2,3 M € | -26.0% | 3,1 M € | +149.2% | 1,3 M € | |
| Debts | 12,5 k € | +134.5% | 5,3 k € | +259.2% | 1,5 k € | -92.6% | 20,0 k € | +35.2% | 14,8 k € | -54.4% | 32,4 k € | -90.4% | 336,1 k € | -83.1% | 2,0 M € | +34532.9% | 5,7 k € | -2.4% | 5,9 k € | +3758.1% | 152,7 € | -96.9% | 5,0 k € | 0.0% | 5,0 k € | -5.2% | 5,3 k € | -19.9% | 6,6 k € | +25.1% | 5,3 k € | |
Public limited company · Zaventem · incorporated on 31/12/2007
Company — Dissolution volontaire – liquidation.
Public limited company loss-making in the latest fiscal year. Cash position declining (-34.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
| Unit no. | Name | Location |
|---|---|---|
| 2167475391 | Vesalius Biocapital ARKIV | Lenneke Marelaan 8, 1932 Zaventem |
VESALIUS BIOCAPITAL ARKIV is a Public limited company incorporated in 2007. Its registered office is in Zaventem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette